A network system for the prevention and treatment of mushroom poisoning in Chuxiong Autonomous Prefecture, Yunnan Province, China: implementation and assessment.

Evaluation Fatality Implementation Mushroom identification Mushroom poisoning Network

Journal

BMC public health
ISSN: 1471-2458
Titre abrégé: BMC Public Health
Pays: England
ID NLM: 100968562

Informations de publication

Date de publication:
11 10 2023
Historique:
received: 20 03 2023
accepted: 02 06 2023
medline: 1 11 2023
pubmed: 12 10 2023
entrez: 11 10 2023
Statut: epublish

Résumé

Mushroom poisoning is a major public health issue in China. The integration of medical resources from different institutes of different levels is crucial in reducing the harm of mushroom poisoning. However, few studies have provided comprehensive implementation procedures and postimplementation effectiveness evaluations. To reduce the harm caused by mushroom poisoning, a network system for the prevention and treatment of mushroom poisoning (NSPTMP) was established in Chuxiong, Yunnan Province, a high-risk area for mushroom poisoning. The NSPTMP consists of three types of institutions, namely, centers for disease prevention, hospitals, and health administration departments, with each kind of institution comprising prefecture, county/city, town, and village levels. After three years of implementation, the network was evaluated by comparing the indices before and after network implementation using data from the "Foodborne Disease Outbreak Surveillance System" and 17 hospitals in Chuxiong. The indices included the fatalities caused by mushroom poisoning, the composition ratios of different types of mushrooms for both outpatients and inpatients and the hospitalization rates. Compared to the average fatality rate of mushroom poisoning from 2015 to 2017, the average fatality rate from 2018 to 2020 significantly decreased from 0.57 to 0.06% (P < 0.001). Regarding the poisonous genus containing lethal mushrooms, the outpatient and inpatient composition ratios significantly decreased for Amanita (9.36-2.91% and 57.23-17.68%, respectively) and Russula (15.27-8.41%) (P < 0.05). Regarding poisonous mushrooms that caused mild symptoms, the outpatient and inpatient composition ratios significantly increased for Scleroderma (5.13-13.90% and 2.89-18.90%, respectively) and Boletaceae (19.08-31.71%) (P < 0.05), and the hospitalization rates significantly increased for Scleroderma (6.33-18.02%) and Boletaceae (5.65-12.71%) (P < 0.05). These findings suggest that the NSPTMP effectively reduced the harm caused by mushroom poisoning. In addition to the integration of medical resources, the development of poisonous mushroom identification, hierarchical treatment systems in hospitals, public education, and professional training also played important roles in improving the system's effectiveness. The establishment and evaluation of the NSPTMP in Chuxiong Prefecture can provide valuable insights and serve as a model for other regions facing similar challenges in managing mushroom poisoning.

Sections du résumé

BACKGROUND
Mushroom poisoning is a major public health issue in China. The integration of medical resources from different institutes of different levels is crucial in reducing the harm of mushroom poisoning. However, few studies have provided comprehensive implementation procedures and postimplementation effectiveness evaluations. To reduce the harm caused by mushroom poisoning, a network system for the prevention and treatment of mushroom poisoning (NSPTMP) was established in Chuxiong, Yunnan Province, a high-risk area for mushroom poisoning.
METHODS
The NSPTMP consists of three types of institutions, namely, centers for disease prevention, hospitals, and health administration departments, with each kind of institution comprising prefecture, county/city, town, and village levels. After three years of implementation, the network was evaluated by comparing the indices before and after network implementation using data from the "Foodborne Disease Outbreak Surveillance System" and 17 hospitals in Chuxiong. The indices included the fatalities caused by mushroom poisoning, the composition ratios of different types of mushrooms for both outpatients and inpatients and the hospitalization rates.
RESULTS
Compared to the average fatality rate of mushroom poisoning from 2015 to 2017, the average fatality rate from 2018 to 2020 significantly decreased from 0.57 to 0.06% (P < 0.001). Regarding the poisonous genus containing lethal mushrooms, the outpatient and inpatient composition ratios significantly decreased for Amanita (9.36-2.91% and 57.23-17.68%, respectively) and Russula (15.27-8.41%) (P < 0.05). Regarding poisonous mushrooms that caused mild symptoms, the outpatient and inpatient composition ratios significantly increased for Scleroderma (5.13-13.90% and 2.89-18.90%, respectively) and Boletaceae (19.08-31.71%) (P < 0.05), and the hospitalization rates significantly increased for Scleroderma (6.33-18.02%) and Boletaceae (5.65-12.71%) (P < 0.05).
CONCLUSIONS
These findings suggest that the NSPTMP effectively reduced the harm caused by mushroom poisoning. In addition to the integration of medical resources, the development of poisonous mushroom identification, hierarchical treatment systems in hospitals, public education, and professional training also played important roles in improving the system's effectiveness. The establishment and evaluation of the NSPTMP in Chuxiong Prefecture can provide valuable insights and serve as a model for other regions facing similar challenges in managing mushroom poisoning.

Identifiants

pubmed: 37821850
doi: 10.1186/s12889-023-16042-7
pii: 10.1186/s12889-023-16042-7
pmc: PMC10568813
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1979

Informations de copyright

© 2023. BioMed Central Ltd., part of Springer Nature.

Références

China CDC Wkly. 2020 Jan 10;2(2):19-24
pubmed: 34594654
Intern Emerg Med. 2018 Jan;13(1):59-67
pubmed: 27988828
Dtsch Arztebl Int. 2020 Oct 16;117(42):701-708
pubmed: 33559585
Hum Exp Toxicol. 2018 Jul;37(7):697-703
pubmed: 28905663
China CDC Wkly. 2021 Jun 11;3(24):518-522
pubmed: 34594925
Toxicon. 2018 Mar 1;143:59-67
pubmed: 29341897
J Toxicol Clin Toxicol. 1991;29(4):459-65
pubmed: 1749051
West J Med. 1998 Dec;169(6):380-4
pubmed: 9866444
Int J Environ Res Public Health. 2018 Dec 14;15(12):
pubmed: 30558129
Food Control. 2018 Feb;84:382-388
pubmed: 32288325
Clin Toxicol (Phila). 2013 Dec;51(10):949-1229
pubmed: 24359283
Crit Care Med. 2005 Feb;33(2):419-26
pubmed: 15699848
Hum Exp Toxicol. 2005 Dec;24(12):609-13
pubmed: 16408613
Food Chem Toxicol. 2019 Jun;128:267-279
pubmed: 30995515
China CDC Wkly. 2022 Jan 21;4(3):35-40
pubmed: 35586461
China CDC Wkly. 2021 Jan 15;3(3):41-45
pubmed: 34594953
Mycologia. 2018 Jul-Aug;110(4):637-641
pubmed: 30062915
J Toxicol Clin Toxicol. 1993;31(1):63-80
pubmed: 8433416
Food Chem Toxicol. 2015 Dec;86:41-55
pubmed: 26375431

Auteurs

Qunmei Yao (Q)

Department of Emergency Medicine, The People's Hospital of Chuxiong Yi Autonomous Prefecture, Chuxiong, 675000, Yunnan, China.

Zhijun Wu (Z)

National Institute for Occupational Health and Poison Control, Chinese Center for Disease Control and Prevention, Beijing, 100050, China.

Jiaju Zhong (J)

Department of Emergency Medicine, The People's Hospital of Chuxiong Yi Autonomous Prefecture, Chuxiong, 675000, Yunnan, China.

Chengmin Yu (C)

Department of Emergency Medicine, The People's Hospital of Chuxiong Yi Autonomous Prefecture, Chuxiong, 675000, Yunnan, China.

Haijiao Li (H)

National Institute for Occupational Health and Poison Control, Chinese Center for Disease Control and Prevention, Beijing, 100050, China.

Qiuling Hu (Q)

Chuxiong Yi Minority Autonomous Prefecture Center for Disease Control and Prevention, Chuxiong, 675000, Yunnan, China.

Jianrong He (J)

Chuxiong Health Commission, Chuxiong, 675000, Yunnan, China.

Jianping Du (J)

Dayao People's Hospital, Dayao, 675400, Yunnan, China.

Chengye Sun (C)

National Institute for Occupational Health and Poison Control, Chinese Center for Disease Control and Prevention, Beijing, 100050, China. suncy@chinacdc.cn.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH